Mckesson Medical-Surgical Inc. Corporate Office recalls Labetalol Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, MFG: Par Pharma, NDC 49884-122-01
Recalled June 15, 2022 · FDA recall D-1094-2022 · Mckesson Medical-Surgical Inc. Corporate Office
Hazard
cGMP deviations: Temperature abuse · FDA Class II
Units
1 bottle/100 tablets
Sold at
USA nationwide.
Description
cGMP deviations: Temperature abuse
Product
Labetalol Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, MFG: Par Pharma, NDC 49884-122-01
Manufacturer(s)
Mckesson Medical-Surgical Inc. Corporate Office
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →